SEC Filings

Form S-1/A
MICROBOT MEDICAL INC. filed this Form S-1/A on 02/08/2019
Document Outline
Entire Document (5699.7 KB)
Subdocument 1 - S-1/A
Page 1 - As filed with the Securities and Exchange Commission on February 7, 2019
Page 2 - The information in this preliminary prospectus is not complete and may be changed. We may not sell t
Page 3 - TABLE OF CONTENTS
Page 4 - PROSPECTUS SUMMARY
Page 5 - Industry Overview
Page 6 - N/A
Page 7 - Our Product Pipeline
Page 8 - Risks Associated with Our Business and this Offering
Page 9 - The Offering
Page 10 - RISK FACTORS
Page 11 - Microbot s ability to expand our technology platforms for other uses, including endovascular neurosu
Page 12 - Risks Related to this Offering
Page 13 - There may be future sales of our securities or other dilution of our equity, which may adversely aff
Page 14 - We are subject to a lawsuit that could adversely affect our business and our use of proceeds from th
Page 15 - SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 16 - USE OF PROCEEDS
Page 17 - INFORMATION REGARDING THE MARKET IN OUR COMMON STOCK
Page 18 - DILUTION
Page 19 - N/A
Page 20 - EXECUTIVE COMPENSATION
Page 21 - Outstanding Equity Awards at Fiscal Year-End
Page 22 - Hezi Himelfarb Employment Agreement
Page 23 - David Ben Naim Services Agreement
Page 24 - N/A
Page 25 - PRINCIPAL STOCKHOLDERS
Page 26 - DESCRIPTION OF CAPITAL STOCK
Page 27 - Outstanding Warrants
Page 28 - DESCRIPTION OF SECURITIES WE ARE OFFERING
Page 29 - UNDERWRITING
Page 30 - Option to Purchase Additional Securities
Page 31 - Indemnification
Page 32 - N/A
Page 33 - N/A
Page 34 - LEGAL MATTERS
Page 35 - N/A
Page 36 - MICROBOT MEDICAL INC.
Page 37 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 38 - MICROBOT MEDICAL INC.
Page 39 - MICROBOT MEDICAL INC.
Page 40 - MICROBOT MEDICAL INC.
Page 41 - MICROBOT MEDICAL INC.
Page 42 - MICROBOT MEDICAL INC.
Page 43 - NOTE 1 - GENERAL
Page 44 - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Page 45 - Level 1 - Quoted prices (unadjusted) in active markets for identical assets and liabilities.
Page 46 - N/A
Page 47 - N/A
Page 48 - NOTE 3 - OTHER CURRENT ASSETS
Page 49 - NOTE 4 - FIXED ASSETS, NET
Page 50 - NOTE 6 - CONVERTIBLE LOAN FROM SHAREHOLDERS
Page 51 - NOTE 7 - DERIVATIVE WARRANT LIABILITIES
Page 52 - N/A
Page 53 - NOTE 8 - COMMITMENTS AND CONTIGENCIES
Page 54 - Lease Agreements:
Page 55 - NOTE 9 - SHARE CAPITAL
Page 56 - Employee stock option grant:
Page 57 - N/A
Page 58 - Shares issued to service provider
Page 59 - Repurchase of Shares
Page 60 - NOTE 11 - RESEARCH AND DEVELOPMENT EXPENSES, NET
Page 61 - NOTE 13 - FINANCE EXPENSES, NET
Page 62 - Reconciliation of Income Taxes:
Page 63 - Share Capital Developments
Page 64 - MICROBOT MEDICAL INC.
Page 65 - MICROBOT MEDICAL INC.
Page 66 - MICROBOT MEDICAL INC.
Page 67 - MICROBOT MEDICAL INC.
Page 68 - NOTE 1 - GENERAL
Page 69 - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Page 70 - NOTE 3 - DERIVATIVE WARRANT LIABILITIES
Page 71 - N/A
Page 72 - NOTE 4 - COMMITMENTS AND CONTINGENCIES
Page 73 - Contract Research Agreement
Page 74 - Agreement with CardioSert Ltd.
Page 75 - Employee Stock Option Grant
Page 76 - N/A
Page 77 - Shares issued to service provider
Page 78 - Securities Exchange Agreement with Alpha Capital
Page 79 - Up to 996,016 Shares of Common Stock
Page 80 - PART II
Page 81 - Item 15. Recent Sales of Unregistered Securities.
Page 82 - Item 16. Exhibits and financial statement schedules.
Page 83 - Item 17. Undertakings.
Page 84 - EXHIBIT INDEX
Page 85 - N/A
Page 86 - SIGNATURES
Page 87 - N/A
Subdocument 2 - EX-1.1 - Underwriting agreement
Page 1 - Exhibit 1.1
Page 2 - Effective Date means the date and time as of which such Registration Statement was declared effectiv
Page 3 - N/A
Page 4 - Schedule V hereto, when taken together with the Pricing Disclosure Package, did not, as of the Appli
Page 5 - N/A
Page 6 - IIA ) nor (ii) is in violation with respect to any instrument of approval granted to it by the Inves
Page 7 - Regulation S-X ) and present fairly, in all material respects, the financial condition, results of o
Page 8 - Critical Accounting Policies ); (ii) the judgments and uncertainties affecting the application of Cr
Page 9 - Specified Equity Plans ), and other issuances and grants, which are disclosed in the Pricing Disclos
Page 10 - Health Care Laws ), except where such noncompliance would not, individually or in the aggregate, hav
Page 11 - Permits ), except where the failure to so possess would not, singly or in the aggregate, reasonably
Page 12 - N/A
Page 13 - Environmental Laws ) applicable to such entity, which compliance includes, without limitation, obtai
Page 14 - ERISA )) for which the Company or any member of its Controlled Group (defined as any organization wh
Page 15 - Investment Company Act ).
Page 16 - Israeli Securities Law ) in Israel, other than an offer that does not constitute an offering to the
Page 17 - OFAC ); and the Company will not directly or indirectly use the proceeds of the offering, or lend, c
Page 18 - Addendum ) who have submitted a written confirmation to the Underwriters and the Company that such i
Page 19 - Underwriter Warrants ) to purchase that number of shares of Common Stock equal to 5% of the aggregat
Page 20 - N/A
Page 21 - N/A
Page 22 - Lock-Up Period ), not to, directly or indirectly, (A) offer, sell, contract to sell, lend, pledge or
Page 23 - Permitted Issuer Information ); provided that (i) no such consent shall be required with respect to
Page 24 - N/A
Page 25 - initial letter ), the Representative shall have received a letter (the bring-down letter ) of such a
Page 26 - N/A
Page 27 - Schedule II, delivered to the Representative on or before the date of this Agreement, shall be in fu
Page 28 - Marketing Materials ), or (E) any Blue Sky application or other document prepared or executed by the
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - Schedule I hereto that, pursuant to this Section 10, purchases Firm Securities or Option Shares that
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - business day means each Monday, Tuesday, Wednesday, Thursday or Friday that is not a day on which ba
Page 37 - N/A
Page 38 - Schedule I hereto
Page 39 - SCHEDULE I
Page 40 - SCHEDULE II
Page 41 - N/A
Page 42 - N/A
Page 43 - N/A
Page 44 - Exhibit A
Page 45 - Exhibit B
Page 46 - Securities Act ), and the Securities Exchange Act of 1934, as amended (the Exchange Act )) to make,
Page 47 - Rule 10b5-1 Plan ) under the Exchange Act; provided, however, that no sales of Common Stock or secur
Page 48 - Other Lock-Up Agreements ) (each such obligor, an Other Holder ), and the undersigned shall not be r
Page 49 - N/A
Page 50 - N/A
Subdocument 3 - EX-4.3 - Instruments defining the rights of security holders
Page 1 - Exhibit 4.3
Page 2 - N/A
Page 3 - The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - NOTICE OF EXERCISE
Page 18 - EXHIBIT B
Page 19 - N/A
Subdocument 4 - EX-4.4 - Instruments defining the rights of security holders
Page 1 - Exhibit 4.4
Page 2 - N/A
Page 3 - The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
Page 4 - $[_____, subject to adjustment hereunder (the Exercise Price ).
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - NOTICE OF EXERCISE
Page 18 - EXHIBIT B
Page 19 - N/A
Subdocument 5 - EX-5.1 - Opinion regarding legality
Page 1 - Exhibit 5.1
Page 2 - Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Page 3 - N/A
Subdocument 6 - EX-23.2 - Consents of experts and counsel
Page 1 - Exhibit 23.2
Page 2 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE FILE (What's this?)
XBRL Item - EX-101.SCH - XBRL SCHEMA FILE (What's this?)
XBRL Item - EX-101.CAL - XBRL CALCULATION FILE (What's this?)
XBRL Item - EX-101.DEF - XBRL DEFINITION FILE (What's this?)
XBRL Item - EX-101.LAB - XBRL LABEL FILE (What's this?)
XBRL Item - EX-101.PRE - XBRL PRESENTATION FILE (What's this?)
XBRL Viewer